Navigation Links
Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
Date:10/18/2010

SAN DIEGO, Oct. 18 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.  This line is located in Althea's large scale & commercial manufacturing facility in San Diego. The expanded capacity complements existing prefilled syringe manufacturing for clinical supplies and allows Althea to provide its clients with drug product in prefilled syringes from early development through commercial supply.

(Logo:  http://photos.prnewswire.com/prnh/20020925/LAW010LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

The INOVA H3-5 syringe line operates within a Restricted Access Barrier System (RABS) and incorporates the ability to fill under vacuum, which facilitates handling of viscous products and products that require minimal head space.  The line accommodates nested syringes from a variety of suppliers and can produce batch sizes in excess of 100,000 units.  The system incorporates non-destructive, in-process weight checks to minimize product loss.  Rick Hancock, President of Contract Manufacturing Services at Althea Technologies, commented, "We've been filling syringes for clinical use for over eight years, and the addition of this new line allows us to continue to meet client requirements as they progress from late stage development through commercialization."

The prefilled syringe market is rapidly expanding as it provides numerous benefits relating to patient compliance and product differentiation.  "With our existing expertise in formulation development and protein analytics, we can now offer clients an integrated solution to quickly develop, register, and launch their products in prefilled syringes," added Dr. Shabbir Anik, CEO of Althea Technologies.

The line will be available for production of GMP batches in Q1, 2011.  Please visit the Althea Technologies website for more detailed information about the new, large scale syringe filling capabilities.

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmid DNA, recombinant proteins, and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation and lyophilization development, and aseptic filling in vials & prefilled syringes for clinical development and commercialization.  Althea's technology platform for protein formulations employs crystalomics that can be applied to a variety of peptide and proteins for high concentration or sustained release formulations.  For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
2. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
3. Visonic Technologies Announces the Immediate Availability of its Elpas Door Kit, an All-in-One Starter Kit Packaged With Everything Required to Install a Single-Door Wandering Patient and Resident Protection Solution
4. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
5. Medical Device Industry Executive Joins OrthoAccel Technologies, Inc. Board of Directors
6. Netsmart Technologies is First Behavioral Healthcare Software Provider to Pass Final Rule ARRA Certification Tests
7. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
8. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
9. HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event
10. Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services
11. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... May 25, 2016  Zymo Research Corp. announced ... new reference materials that help researchers obtain the ... to analyses. The rapid growth of the study ... to have standard methods to improve the reproducibility ... inherently exist at every step of the measurement ...
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today ... test for wounds and infections. This test ensures ... and select viruses. The test requires only a ... David G. Bostwick , MD, ... to facilitate wound healing: "We are excited to ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting ... and company to wait until March 2017 for an interest rate increase, according to ... College of Business. , “The Federal Open Market Committee (FOMC) dot charts are of ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to expand ... Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final WNBA ... levels of the game, Connor Sports has committed to a significantly increased focus on ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
Breaking Medicine News(10 mins):